Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.34 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.34 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.34 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.34 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27900336 | 0.80 | MEN1 (0.32) | — | |
| SCHEMBL28267133 | 0.79 | TSHR (0.31) | — | |
| SCHEMBL27541532 | 0.77 | CNR2 (0.38) | — | |
| SCHEMBL27546682 | 0.77 | KDM4C (0.35) | — | |
| SCHEMBL20442266 | 0.77 | DGAT1 (0.30) | — | |
| SCHEMBL27707300 | 0.75 | — | — | |
| SCHEMBL15746523 | 0.75 | — | — | |
| Ammonia Solution, Strong SCHEMBL28029565 | 0.75 | CNR2 (0.37) | — | |
| SCHEMBL18030760 | 0.73 | TSHR (0.34) | ALDH1A1 | |
| SCHEMBL27856421 | 0.73 | TDP1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108677-A | Zwitterionic modified polymers and hydrogels | 康奈尔大学 | 2024-05-31 | — | — | CN | disclosed |
| CN-110381956-B | Zwitterionic modified polymers and hydrogels | 康奈尔大学 | 2024-02-02 | — | — | CN | disclosed |
| US-20240018276-A1 | ZWITTERIONICALLY MODIFIED POLYMERS AND HYDROGELS | UNIV CORNELL (US) | 2024-01-18 | — | — | US | disclosed |
| US-11634512-B2 | Zwitterionically modified polymers and hydrogels | CORNELL UNIVERSITY (US) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018276-A1 | ZWITTERIONICALLY MODIFIED POLYMERS AND HYDROGELS | CHRM1, CHRM2, F12 | PRMT3 140/4885CARM1 127/4885PRMT6 92/4885 |
| US-11634512-B2 | Zwitterionically modified polymers and hydrogels | CHRM1, CHRM2, F12 | PRMT3 143/4885CARM1 130/4885PRMT6 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.